Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy

BACKGROUND: A favorable model for predicting disease-free survival (DFS) and stratifying prognostic risk in breast cancer (BC) treated with neoadjuvant chemotherapy (NAC) is lacking. The aim of the current study was to formulate an excellent model specially for predicting prognosis in these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, N., Wu, J., Xiao, J., Wang, Z., Song, Z., Ke, Z., Wang, R., Wei, M., Xu, M., Wei, J., Qian, X., Xu, X., Yi, J., Wang, T., Zhang, J., Li, N., Fan, J., Hou, G., Wang, Y., Ling, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455687/
https://www.ncbi.nlm.nih.gov/pubmed/34537675
http://dx.doi.org/10.1016/j.esmoop.2021.100269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455687/
https://www.ncbi.nlm.nih.gov/pubmed/34537675
http://dx.doi.org/10.1016/j.esmoop.2021.100269

Ejemplares similares